Privia Health Group Inc

Privia Health Group Inc (PRVA) Stock Analysis

$22.620

+0.991 (+4.38%)At close

Loading chart…
High
22.730
Open
21.970
VWAP
22.41
Volume
2.00M
Mkt Cap
2.04B
Low
21.885
Amount
44.87M
EV/EBITDA, TTM
-6,438.54

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.

AI analysis of Privia Health Group Inc (PRVA)

Buy

Privia Health Group Inc is a good buy right now due to its current price of $20.85, which is significantly below the analyst price target of $35, indicating a potential upside of 68%. Additionally, the company reported a solid 12.4% year-over-year increase in practice collections for Q2 2026, showcasing strong operational performance. However, a risk to consider is the recent EPS surprise of -12.5%, which may affect short-term investor sentiment.

Valuation Metrics

The current forward P/E ratio for Privia Health Group Inc (PRVA) is 17.27, compared to its 5-year average forward P/E of 59.16.

Forward P/E

Fair
5Y Average P/E
59.16
Current P/E
17.27
Overvalued
343.85
Undervalued
-225.53

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
-109.44
Current EV/EBITDA
-6438.54
Overvalued
992.97
Undervalued
-1211.86

Forward P/S

Undervalued
5Y Average P/S
1.61
Current P/S
1.03
Overvalued
2.11
Undervalued
1.11

Alphio AI Price Scenarios for PRVA

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%PRVA

$29.18

Scenario price

B

Base

Base · 50%PRVA

$27.83

Scenario price

B

Bear

Bear · 25%PRVA

$24.83

Scenario price

Whales holding PRVA

R

Riverbridge Partners, LLC

+ HoldingPRVA

+4.83%

3M Return

D

Durable Capital Partners, LP

+ HoldingPRVA

-3.58%

3M Return

Events Timeline

2026-08-06 (ET)

06:30:00

Company Reports Q2 Revenue of $632.6M

06:30:00

FY26 Consensus at $2.42, Adjusted EBITDA Expected in $145M-$155M Range

2026-05-27 (ET)

09:10:00

Privia Health Signs Agreement with NGBC to Enter New Jersey

2026-05-07 (ET)

06:20:00

Company Reports Q1 Revenue of $603.8M, Exceeds Consensus

2026-02-26 (ET)

06:30:00

Expects Approximately $600M in Cash by Year-End 2026

News

PRVA FAQ — answered by Alphio AI

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

Privia Health Group Inc is a good buy right now due to its current price of $20.85, which is significantly below the analyst price target of $35, indicating a potential upside of 68%. Additionally, the company reported a solid 12.4% year-over-year increase in practice collections for Q2 2026, showcasing strong operational performance. However, a risk to consider is the recent EPS surprise of -12.5%, which may affect short-term investor sentiment.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading